In Vitro pancreatic ductal cell carcinogenesis

Yoshito Ikematsu, Guozhen Liu, Margery A. Fienhold, Martin Cano, Thomas E. Adrian, Michael A Hollingsworth, Janet E. Williamson, Warren Sanger, Tsutomu Tomioka, Parviz M. Pour

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Our experiments were designed to identify initial biochemical and biological changes that occur during pancreatic carcinogenesis. TAKA-1, an immortal hamster pancreatic ductal cell line, was treated in vitro for up to 11 weeks with the pancreatic carcinogen N-nitorosobis(2-oxopropyl)amine (BOP). These treated cells were designated TAKA-1 + BOP. The growth of TAKA-1 and TAKA-1 + BOP cell lines was investigated in soft agar and in hamsters intradermally. The resulting tumor from TAKA-1 + BOP was re- cultured in vitro and designated TAKA-1 + BOP-T. Mutation of c-K-ras and p53 oncogenes, chromosomal changes, expression of transforming growth factor alpha (TGF-α) and epidermal growth factor (EGF) receptor and several biochemical markers were examined in all cell lines. TAKA-1 + BOP but not TAKA-1 cells grew in soft agar and produced an invasive tumor in vivo. However, there were no differences in cell growth rate, DNA flow cytometry, or immunohistochemical findings between the non-transformed and transformed cells. TAKA-1, TAKA-1 + BOP and TAKA-1 + BOP-T cells all expressed mRNA of TGF-α and EGF receptor in a comparable pattern. DNA sequence analysis following polymerase chain reaction showed that neither TAKA-1 nor TAKA-1 + BOP cells has a mutation of c-K-ras or p53. Karyotype analysis demonstrated that TAKA-1 + BOP cells had more chromosomal abnormalities compared with TAKA-1 cells. Mutation of c-K-ras and p53 was not essential for carcinogenesis in hamster pancreatic ductal cells in vitro. In conclusion, immortality of the TAKA-1 cells caused expression of TGF-α to the same extent as in malignant cells. Chromosomal and ultrastructural patterns were the only differences detected between the non-transformed and BOP-transformed cells.

Original languageEnglish (US)
Pages (from-to)1095-1103
Number of pages9
JournalInternational Journal of Cancer
Volume72
Issue number6
DOIs
StatePublished - Sep 17 1997

Fingerprint

Carcinogenesis
Transforming Growth Factor alpha
Cricetinae
Epidermal Growth Factor Receptor
Cell Line
Mutation
Agar
In Vitro Techniques
ras Genes
Growth
Karyotype
DNA Sequence Analysis
Chromosome Aberrations
Carcinogens
Amines
Neoplasms
Flow Cytometry
Biomarkers
T-Lymphocytes
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

In Vitro pancreatic ductal cell carcinogenesis. / Ikematsu, Yoshito; Liu, Guozhen; Fienhold, Margery A.; Cano, Martin; Adrian, Thomas E.; Hollingsworth, Michael A; Williamson, Janet E.; Sanger, Warren; Tomioka, Tsutomu; Pour, Parviz M.

In: International Journal of Cancer, Vol. 72, No. 6, 17.09.1997, p. 1095-1103.

Research output: Contribution to journalArticle

Ikematsu, Y, Liu, G, Fienhold, MA, Cano, M, Adrian, TE, Hollingsworth, MA, Williamson, JE, Sanger, W, Tomioka, T & Pour, PM 1997, 'In Vitro pancreatic ductal cell carcinogenesis', International Journal of Cancer, vol. 72, no. 6, pp. 1095-1103. https://doi.org/10.1002/(SICI)1097-0215(19970917)72:6<1095::AID-IJC26>3.0.CO;2-2
Ikematsu, Yoshito ; Liu, Guozhen ; Fienhold, Margery A. ; Cano, Martin ; Adrian, Thomas E. ; Hollingsworth, Michael A ; Williamson, Janet E. ; Sanger, Warren ; Tomioka, Tsutomu ; Pour, Parviz M. / In Vitro pancreatic ductal cell carcinogenesis. In: International Journal of Cancer. 1997 ; Vol. 72, No. 6. pp. 1095-1103.
@article{094a50eed84449c19639ce021215497e,
title = "In Vitro pancreatic ductal cell carcinogenesis",
abstract = "Our experiments were designed to identify initial biochemical and biological changes that occur during pancreatic carcinogenesis. TAKA-1, an immortal hamster pancreatic ductal cell line, was treated in vitro for up to 11 weeks with the pancreatic carcinogen N-nitorosobis(2-oxopropyl)amine (BOP). These treated cells were designated TAKA-1 + BOP. The growth of TAKA-1 and TAKA-1 + BOP cell lines was investigated in soft agar and in hamsters intradermally. The resulting tumor from TAKA-1 + BOP was re- cultured in vitro and designated TAKA-1 + BOP-T. Mutation of c-K-ras and p53 oncogenes, chromosomal changes, expression of transforming growth factor alpha (TGF-α) and epidermal growth factor (EGF) receptor and several biochemical markers were examined in all cell lines. TAKA-1 + BOP but not TAKA-1 cells grew in soft agar and produced an invasive tumor in vivo. However, there were no differences in cell growth rate, DNA flow cytometry, or immunohistochemical findings between the non-transformed and transformed cells. TAKA-1, TAKA-1 + BOP and TAKA-1 + BOP-T cells all expressed mRNA of TGF-α and EGF receptor in a comparable pattern. DNA sequence analysis following polymerase chain reaction showed that neither TAKA-1 nor TAKA-1 + BOP cells has a mutation of c-K-ras or p53. Karyotype analysis demonstrated that TAKA-1 + BOP cells had more chromosomal abnormalities compared with TAKA-1 cells. Mutation of c-K-ras and p53 was not essential for carcinogenesis in hamster pancreatic ductal cells in vitro. In conclusion, immortality of the TAKA-1 cells caused expression of TGF-α to the same extent as in malignant cells. Chromosomal and ultrastructural patterns were the only differences detected between the non-transformed and BOP-transformed cells.",
author = "Yoshito Ikematsu and Guozhen Liu and Fienhold, {Margery A.} and Martin Cano and Adrian, {Thomas E.} and Hollingsworth, {Michael A} and Williamson, {Janet E.} and Warren Sanger and Tsutomu Tomioka and Pour, {Parviz M.}",
year = "1997",
month = "9",
day = "17",
doi = "10.1002/(SICI)1097-0215(19970917)72:6<1095::AID-IJC26>3.0.CO;2-2",
language = "English (US)",
volume = "72",
pages = "1095--1103",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - In Vitro pancreatic ductal cell carcinogenesis

AU - Ikematsu, Yoshito

AU - Liu, Guozhen

AU - Fienhold, Margery A.

AU - Cano, Martin

AU - Adrian, Thomas E.

AU - Hollingsworth, Michael A

AU - Williamson, Janet E.

AU - Sanger, Warren

AU - Tomioka, Tsutomu

AU - Pour, Parviz M.

PY - 1997/9/17

Y1 - 1997/9/17

N2 - Our experiments were designed to identify initial biochemical and biological changes that occur during pancreatic carcinogenesis. TAKA-1, an immortal hamster pancreatic ductal cell line, was treated in vitro for up to 11 weeks with the pancreatic carcinogen N-nitorosobis(2-oxopropyl)amine (BOP). These treated cells were designated TAKA-1 + BOP. The growth of TAKA-1 and TAKA-1 + BOP cell lines was investigated in soft agar and in hamsters intradermally. The resulting tumor from TAKA-1 + BOP was re- cultured in vitro and designated TAKA-1 + BOP-T. Mutation of c-K-ras and p53 oncogenes, chromosomal changes, expression of transforming growth factor alpha (TGF-α) and epidermal growth factor (EGF) receptor and several biochemical markers were examined in all cell lines. TAKA-1 + BOP but not TAKA-1 cells grew in soft agar and produced an invasive tumor in vivo. However, there were no differences in cell growth rate, DNA flow cytometry, or immunohistochemical findings between the non-transformed and transformed cells. TAKA-1, TAKA-1 + BOP and TAKA-1 + BOP-T cells all expressed mRNA of TGF-α and EGF receptor in a comparable pattern. DNA sequence analysis following polymerase chain reaction showed that neither TAKA-1 nor TAKA-1 + BOP cells has a mutation of c-K-ras or p53. Karyotype analysis demonstrated that TAKA-1 + BOP cells had more chromosomal abnormalities compared with TAKA-1 cells. Mutation of c-K-ras and p53 was not essential for carcinogenesis in hamster pancreatic ductal cells in vitro. In conclusion, immortality of the TAKA-1 cells caused expression of TGF-α to the same extent as in malignant cells. Chromosomal and ultrastructural patterns were the only differences detected between the non-transformed and BOP-transformed cells.

AB - Our experiments were designed to identify initial biochemical and biological changes that occur during pancreatic carcinogenesis. TAKA-1, an immortal hamster pancreatic ductal cell line, was treated in vitro for up to 11 weeks with the pancreatic carcinogen N-nitorosobis(2-oxopropyl)amine (BOP). These treated cells were designated TAKA-1 + BOP. The growth of TAKA-1 and TAKA-1 + BOP cell lines was investigated in soft agar and in hamsters intradermally. The resulting tumor from TAKA-1 + BOP was re- cultured in vitro and designated TAKA-1 + BOP-T. Mutation of c-K-ras and p53 oncogenes, chromosomal changes, expression of transforming growth factor alpha (TGF-α) and epidermal growth factor (EGF) receptor and several biochemical markers were examined in all cell lines. TAKA-1 + BOP but not TAKA-1 cells grew in soft agar and produced an invasive tumor in vivo. However, there were no differences in cell growth rate, DNA flow cytometry, or immunohistochemical findings between the non-transformed and transformed cells. TAKA-1, TAKA-1 + BOP and TAKA-1 + BOP-T cells all expressed mRNA of TGF-α and EGF receptor in a comparable pattern. DNA sequence analysis following polymerase chain reaction showed that neither TAKA-1 nor TAKA-1 + BOP cells has a mutation of c-K-ras or p53. Karyotype analysis demonstrated that TAKA-1 + BOP cells had more chromosomal abnormalities compared with TAKA-1 cells. Mutation of c-K-ras and p53 was not essential for carcinogenesis in hamster pancreatic ductal cells in vitro. In conclusion, immortality of the TAKA-1 cells caused expression of TGF-α to the same extent as in malignant cells. Chromosomal and ultrastructural patterns were the only differences detected between the non-transformed and BOP-transformed cells.

UR - http://www.scopus.com/inward/record.url?scp=0030862043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030862043&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19970917)72:6<1095::AID-IJC26>3.0.CO;2-2

DO - 10.1002/(SICI)1097-0215(19970917)72:6<1095::AID-IJC26>3.0.CO;2-2

M3 - Article

VL - 72

SP - 1095

EP - 1103

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -